Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study
Background: Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—diff...
Similar Items
-
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
by: Chow C.K.; Nguyen T.N.; Marschner S.; Diaz R.; Rahman O.; Avezum A.; Lear S.A.; Teo K.; Yeates K.E.; Lanas F.; Li W.; Hu B.; Lopez-Jaramillo P.; Gupta R.; Kumar R.; Mony P.K.; Bahonar A.; Yusoff K.; Khatib R.; Kazmi K.; Dans A.L.; Zatonska K.; Alhabib K.F.; Kruger I.M.; Rosengren A.; Gulec S.; Yusufali A.; Chifamba J.; Rangarajan S.; McKee M.; Yusuf S.
Published: (2020) -
Association of Sitting Time with Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries
by: Li S.; Lear S.A.; Rangarajan S.; Hu B.; Yin L.; Bangdiwala S.I.; Alhabib K.F.; Rosengren A.; Gupta R.; Mony P.K.; Wielgosz A.; Rahman O.; Mazapuspavina M.Y.; Avezum A.; Oguz A.; Yeates K.; Lanas F.; Dans A.; Abat M.E.M.; Yusufali A.; Diaz R.; Lopez-Jaramillo P.; Leach L.; Lakshmi P.V.M.; Basiak-Rasała A.; Iqbal R.; Kelishadi R.; Chifamba J.; Khatib R.; Li W.; Yusuf S.
Published: (2022) -
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
by: Chow C.K.; Ramasundarahettige C.; Hu W.; AlHabib K.F.; Avezum A., et al.
Published: (2018) -
Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study
by: Walli-Attaei M.; Rosengren A.; Rangarajan S.; Breet Y.; Abdul-Razak S.; Sharief W.A.; Alhabib K.F.; Avezum A.; Chifamba J.; Diaz R.; Gupta R.; Hu B.; Iqbal R.; Ismail R.; Kelishadi R.; Khatib R.; Lang X.; Li S.; Lopez-Jaramillo P.; Mohan V.; Oguz A.; Palileo-Villanueva L.M.; Poltyn-Zaradna K.; R S.P.; Pinnaka L.V.M.; Serón P.; Teo K.; Verghese S.T.; Wielgosz A.; Yeates K.; Yusuf R.; Anand S.S.; Yusuf S.
Published: (2022) -
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: An analysis of the PURE study data
by: Khatib R.; McKee M.; Shannon H.; Chow C.; Rangarajan S.; Teo K.; Wei L.; Mony P.; Mohan V.; Gupta R.; Kumar R.; Vijayakumar K.; Lear S.A.; Diaz R.; Avezum A.; Lopez-Jaramillo P.; Lanas F.; Yusoff K.; Ismail N.; Kazmi K.; Rahman O.; Rosengren A.; Monsef N.; Kelishadi R.; Kruger A.; Puoane T.; Szuba A.; Chifamba J.; Temizhan A.; Dagenais G.; Gafni A.; Yusuf S.
Published: (2016)